Earnings Call · Q4 FY2025·2026-03-17

Q4 25EPS -9.37%·Rev n/aQ3 25EPS +67.65%·Rev n/aQ2 25EPS -20.51%·Rev n/aQ1 25EPS +31.43%·Rev n/a⚠ consensus missing

ABEONA THERAPEUTICS INC. ABEO

Vishwas Seshadri — Chief Executive Officer

Madhav Vasanthavada — Chief Commercial Officer

Joseph Walter Vazzano — Chief Financial Officer

−3.8%1d on move date−4.1% vs SPY3d−8.3%5d−10.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABEO calls or request research access.

More ABEO calls Browse calls Request research access